Impact of RYALTRIS® Nasal Spray on Patients’ Reported Outcomes
Condition(s):Allergic RhinitisLast Updated:April 7, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Allergic RhinitisLast Updated:April 7, 2022Withdrawn
Condition(s):Allergic Rhinitis Due to Weed Pollen; MontelukastLast Updated:September 10, 2021Completed
Condition(s):Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency; ATP-Binding Cassette Subfamily C Member 6 DeficiencyLast Updated:March 18, 2024Not yet recruiting
Condition(s):SinusitisLast Updated:October 19, 2018Terminated
Condition(s):Chronic Sinusitis; Chronic Rhinosinusitis (Diagnosis)Last Updated:September 21, 2023Completed
Condition(s):Seasonal Allergic Rhinitis (SAR)Last Updated:April 6, 2018Completed
Condition(s):Head and Neck NeoplasmsLast Updated:March 24, 2020Completed
Condition(s):Allergic RhinitisLast Updated:October 1, 2015Completed
Condition(s):Degenerative Disc Disease; Spinal StenosisLast Updated:February 9, 2024Recruiting
Condition(s):Rhinitis, Allergic, SeasonalLast Updated:September 6, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.